| 000 | 01571 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514162817.0 | ||
| 264 | 0 | _c20040621 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/s00228-003-0697-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolstein, A | |
| 245 | 0 | 0 |
_aHormonal counterregulation and consecutive glimepiride serum concentrations during severe hypoglycaemia associated with glimepiride therapy. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _cDec 2003 |
||
| 300 |
_a747-54 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlucose |
| 650 | 0 | 4 |
_aHormones _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xadverse effects |
| 700 | 1 | _aPlaschke, A | |
| 700 | 1 | _aHammer, C | |
| 700 | 1 | _aPtak, M | |
| 700 | 1 | _aKuhn, J | |
| 700 | 1 | _aKratzsch, C | |
| 700 | 1 | _aDiekmann, J | |
| 700 | 1 | _aKleesiek, K | |
| 700 | 1 | _aMaurer, H H | |
| 700 | 1 | _aEgberts, E-H | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 59 _gno. 10 _gp. 747-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00228-003-0697-9 _zAvailable from publisher's website |
| 999 |
_c14370833 _d14370833 |
||